Werewolf Therapeutics Inc...

1.14
-0.10 (-8.06%)
At close: Mar 03, 2025, 3:59 PM
1.14
0.57%
After-hours: Mar 03, 2025, 05:01 PM EST

Werewolf Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19
Net Income -37.37M -53.81M -49.98M -15.04M -10.25M
Depreciation & Amortization 1.76M 1.1M 216K 150K 25K
Stock-Based Compensation 8.01M 7.4M 4.09M 632K 559K
Other Working Capital -7.14M 3.42M 1.27M 1.92M -827K
Other Non-Cash Items 878K 2.17M 519K 627K 950K
Deferred Income Tax n/a n/a n/a -7.3M -117K
Change in Working Capital -5.89M 2.54M 2.28M 2.31M -711K
Operating Cash Flow -32.61M -40.6M -42.88M -18.62M -9.54M
Capital Expenditures -769K -3.61M -498K -560K -266K
Acquisitions n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a
Investing Cash Flow -769K -3.61M -498K -560K -266K
Debt Repayment 40M n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 100K 166K -2.17M 94.02M 21.91M
Financial Cash Flow 58.43M 15.91M 109.43M 93.86M 21.91M
Net Cash Flow 25.05M -28.3M 66.05M 74.67M 12.1M
Free Cash Flow -33.38M -44.21M -43.37M -19.18M -9.81M